Publication: Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine
4
item.page.dc.date.issued
2004-01-01
item.page.dc.type
item.page.dc.identifier.issn
00207519
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-0346727212
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
International Journal for Parasitology. Vol.34, No.1 (2004), 95-100
punsarn.item.page.citation
Janette Berglez, Peter Iliades, Worachart Sirawaraporn, Peter Coloe, Ian Macreadie Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine. International Journal for Parasitology. Vol.34, No.1 (2004), 95-100. doi:10.1016/j.ijpara.2003.09.009 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21419
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Mutations in Plasmodium falciparum dihydropteroate synthase have been linked to resistance to the antimalarial drug, sulfadoxine, which competes with the dihydropteroate synthase substrate, p-aminobenzoate. In an effort to evaluate the role of these mutations in a simple model system, we have expressed six relevant alleles of the P. falciparum dihydropteroate synthase gene in Escherichia coli. When each construct was produced in a dihydropteroate synthase disrupted E. coli strain that required thymidine, the thymidine requirement was lost, indicating heterologous complementation had occurred. In the presence of sulfadoxine, the growth of the strain with the wild-type dihydropteroate synthase allele was inhibited while those containing each of the five mutant alleles grew, indicating that these mutations can confer sulfadoxine resistance in E. coli. When tested against twelve additional 'sulfa' drugs a variety of responses were obtained. All strains were resistant to sulfadiazine, but the wild-type allele conferred sensitivity to all other sulfa drugs. Three alleles conferred resistance to dapsone, a drug that is to be targetted for a new regime of malaria treatment in Africa. All mutant alleles remained sensitive to sulfachloropyridazine and sulfacetamide. These results suggest new drugs that could be tried for effective malaria treatment. © 2003 on behalf of Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.